The job cuts reflect the normal maturation of companies such as Alameda-based Scribe, which is moving from a preclinical to ...

On Monday, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) regained the development and commercialization rights to giroctocogene fitelparvovec, an investigational gene therapy product candidate for ...

WEXFORD, Pa., Dec. 26, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company specializing ...

Keros Therapeutics paused 3.0 mg/kg and 4.5 mg/kg dosing in the TROPOS trial due to adverse pericardial effusion events. Dosing at 1.5 mg/kg continues; topline data for all arms expected in Q2 2025.

Chroma Medicine and Nvelop Therapeutics merge to bring together best-in-class epigenetic editing technologies and next generation in vivo delivery technologies to unlock the full potential of ...

Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Last year, Akero Therapeutics’ shares soared after the company reported success in a study of its drug that mimics the effects of FGF21 in NASH patients. Kriya and Tramontane are trying to develop a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...